Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

BMC Cancer

Topics

Economics

Cancer Oncology

Medicine

Internal Medicine

Surgery

Show all topics

DOI

10.1186/1471-2407-12-305

License

CC-BY

Other Formats

PDF